Home
>
National Drug Code (NDC)
>
HyperRAB S/D
HyperRAB S/D - 13533-618-02 - (Human Rabies Virus Immune Globulin)
Drug Information of HyperRAB S/D
| Product NDC: | 13533-618 |
| Proprietary Name: | HyperRAB S/D |
| Non Proprietary Name: | Human Rabies Virus Immune Globulin |
| Active Ingredient(s): | 150 [iU]/mL & nbsp; Human Rabies Virus Immune Globulin |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HyperRAB S/D
| Product NDC: | 13533-618 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101144 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19960814 |
Package Information of HyperRAB S/D
| Package NDC: | 13533-618-02 |
| Package Description: | 1 VIAL, GLASS in 1 CARTON (13533-618-02) > 2 mL in 1 VIAL, GLASS (13533-618-20) |
NDC Information of HyperRAB S/D
| NDC Code | 13533-618-02 |
| Proprietary Name | HyperRAB S/D |
| Package Description | 1 VIAL, GLASS in 1 CARTON (13533-618-02) > 2 mL in 1 VIAL, GLASS (13533-618-20) |
| Product NDC | 13533-618 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Human Rabies Virus Immune Globulin |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19960814 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | HUMAN RABIES VIRUS IMMUNE GLOBULIN |
| Strength Number | 150 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes |
